DE | EN
Book an initial consultation

Services · GMP and GxP Consulting & QA Support

Validate and qualify before the audit finds the gaps.

A process that has not been validated, equipment that has not been qualified, a quality system with gaps, and no one with the time to deal with them. A&O Pharma provides an experienced consultant who sets up your quality management system, validates processes, qualifies premises and equipment from DQ to PQ and puts quality processes in place in line with GMP, for predictable costs and consistent product quality.

GxP audits DQ-IQ-OQ-PQ Process validation

No obligation, in confidence. We reply within one to two working days.

§ 3 AMWHV / ICH Q10
Quality management system in practice
ICH Q9
Identifying, assessing and controlling risks
DQ-IQ-OQ-PQ
Complete qualification of equipment and premises

As long as methods and processes are not validated and premises and equipment are not qualified, your plant produces stock rather than released product, and your business stalls.

The question that matters

Is it enough to validate the process, or does the equipment also need to be requalified?

Only rarely does everything need to be redone. What matters is not the scope but a sound, practical risk-based assessment that safeguards productivity and quality after a change. We assess what has actually changed and what it affects, and from that we determine what needs to be validated, what needs to be requalified and how it must be documented. This usually saves far more effort than the assessment itself costs, and gives you confidence that you can continue to produce reliably.

Validated methods and processes and qualified machinery and equipment are essential for manufacturing your products reliably and without errors. They allow you to assure consistent quality at a predictable cost. Poor product quality, by contrast, leads to high and unpredictable costs. Well-designed validation and qualification therefore pay off, both for patients and for you as the manufacturer.

What we take on for you

  • Analytical method validation: developing your analytical methods, drawing up validation plans, performing the validation and preparing comprehensive validation reports. Only validated methods give you analytical results you can rely on, and you need those as early as the development phase.
  • Qualification of equipment and premises: risk assessments and support through all qualification phases: design qualification (DQ), installation qualification (IQ), operational qualification (OQ) and performance qualification (PQ).
  • Process transfer and validation: risk-based planning of your product transfer and process validation, traditional or continuous, including the GMP process validation report.
  • GxP audits: audits of service providers and suppliers must be carried out by qualified internal or external auditors. We then help you assess and follow up the proposed CAPAs.
  • Setting up and improving a quality management system: whether reviewing an existing system or building a new one, we set up an efficient quality management system with the perspective of a neutral third party.
  • Education and training: Part I, Chapter 2.11 of the EU GMP Guide requires basic training plus task-specific training for new staff, as well as continuing training with periodic assessment. We tailor planning and delivery to your situation and needs.
  • Support during regulatory inspections: preparation from the perspective of an independent observer and support during the inspection, whether by your local authority or by a foreign regulator.

The regulatory framework

  • EU GMP Guide, including Part I, Chapter 2.11 on training.
  • ICH Q2 as the basis for analytical method validation.
  • EU GMP Guide Annex 15: DQ, IQ, OQ and PQ as the established sequence of qualification phases.
  • ICH Q10 as the basis of a pharmaceutical quality system.

Roles we take on

The roles we can fill for you.

Process

From enquiry to a working pharmaceutical quality system (PQS).

4 steps, one dedicated contact, no surprises.

Book an initial consultation
01

Gap assessment

What exists, what your goals are and what is missing. Usually more is in place than expected, it just has not been documented.

02

Risk assessment and plan

Together we decide what needs to be created, validated and qualified, how, and in what order.

03

Implementation

Creating or revising the quality system, process and method validation, qualification from DQ to PQ. On request, with analytical testing from our own laboratory.

04

Quality system and inspection

You receive a quality system and reports that stand up to scrutiny. On request, we are with you during the inspection.

Typical starting points

Does one of these sound familiar?

Before your first inspection

A new site, a new product or new equipment, and the authority has announced an inspection. You need someone who knows what inspectors will look at.

After an audit finding

An audit has revealed gaps, and your response needs to be robust, not just fast. An inadequate response only leads to the next finding.

During a product transfer

A process is moving to another line or another plant. Without proper transfer and process validation, batch release is at risk.

Setting up a quality management system

You are growing, or you need a system for the first time that is more than a collection of files.

Responsibility

Who is accountable for this.

You get the name, statutory role and direct phone number of the person handling your project before the contract starts, not afterwards. A named person, not a team.

Sascha Manthei

Sascha Manthei

Business Development

QP

Key areas

  • Qualified Person under § 14 AMG
  • Pharmaceutical quality management
  • GMP consulting
  • Auditor

Banking apprenticeship, degree in pharmacy, licence to practise as a pharmacist, Master of Business Administration (MBA)

Dr. Olaf Mundszinger

Dr. Olaf Mundszinger

Founder and Managing Director

QP

Key areas

  • Pharmaceutical quality control and quality assurance
  • Narcotics Officer
  • IMPD preparation
  • Pharmaceutical analysis

Doctorate in analytical chemistry, degree in pharmaceutical sciences and chemistry

Leidy Fajardo

Leidy Fajardo

Risk Assessment and GMP Documentation

Key areas

  • Risk assessment
  • GMP documentation
  • Data science

B.Sc. Pharmaceutical Chemistry, M.Sc. Biomedical Informatics, specialisation in strategic corporate management

Dr. Emmanuel Bey

Dr. Emmanuel Bey

Analytical Development

QP

Key areas

  • Analytical development, including validation and transfer of analytical methods
  • IMPD and dossier preparation

Doctorate in pharmaceutical chemistry

Tatjana Pazer

Tatjana Pazer

Quality Management and Sterile Manufacturing

QP

Key areas

  • Sterile manufacturing and compounding
  • Computer system validation
  • Lean, efficient quality management
  • Auditor

Degree in pharmacy, licence to practise as a pharmacist, pharmaceutical technical assistant

Dr. Klaus-Peter Kreth

Dr. Klaus-Peter Kreth

Qualified Person (QP) under § 14 AMG

QP

Key areas

  • Quality management
  • Operational QA
  • Inspection preparation, support and follow-up
  • Auditor

Licence to practise as a pharmacist, doctorate in pharmaceutical analysis, specialist pharmacist in pharmaceutical analysis

Alexander Trautmann

Alexander Trautmann

GMP Consulting and Training

Key areas

  • GMP consulting
  • GMP training
  • ISO 13485, MDR and IVDR
  • Regulatory inspections

Licence to practise as a pharmacist

Dr. Thomas Lutz

Dr. Thomas Lutz

Qualified Person (QP) and Head of Production

QP

Key areas

  • Qualified Person under § 14 AMG
  • Head of Production under the AMWHV
  • Responsible person for wholesale distribution of medicinal products under § 52a AMG
  • Stufenplanbeauftragter under § 19(7) AMWHV

Degree in pharmacy, licence to practise as a pharmacist, doctorate in pharmaceutical chemistry

Dr. Kai Huwig

Dr. Kai Huwig

Qualified Person (QP) and Head of Quality Control

QP

Key areas

  • Qualified Person under § 14 AMG
  • Validation of analytical methods
  • Head of Quality Control under the AMWHV

Degree and doctorate in chemistry, postgraduate pharmacy programme to acquire the expert knowledge required under § 15 AMG

Case studies

Problems we have solved in this area.

Anonymised projects from this service: starting point, approach and outcome.

Clinical trial sponsor, small biotech company

From IMPD to QP release, all from a single provider

A new active substance from a non-EU country was to be used in a phase 1 trial as an investigational medicinal product. We provided GMP oversight, pro...

Read the full case study

Innovative biotech company in cancer therapeutics

Setting up a GMP manufacturing facility for peptide vaccines

A research institution is setting up a GMP manufacturing facility for personalised peptide vaccines. We are supporting it from regulatory classificati...

Read the full case study

Mid-sized pharmaceutical company and marketing authorisation holder

Qualified Person (QP) and Head of Production provided

A marketing authorisation holder needed a Qualified Person (QP) for batch release and, for a period, a Head of Production. We provided both, and busin...

Read the full case study

Mid-sized company, marketing authorisation holder

Manufacturing site transfer: CMC review, transfer plan and support

A marketing authorisation holder is planning to change its manufacturer. We reviewed the CMC documentation, made recommendations on selecting a contra...

Read the full case study

Mid-sized contract manufacturer of medicinal products

QP batch release after EU import for a Swiss contract manufacturer

A Swiss contract manufacturer needs batch release for its authorised medicinal products after import into the EU. We release every batch on an ongoing...

Read the full case study

Clinical trial sponsor, small biotech company

Third-country active substance: QP release for a clinical trial

Active substance from a non-EU country, investigational medicinal product for a trial in several European countries: we provided GMP oversight, the IM...

Read the full case study

Frequently asked questions about GMP and GxP Consulting & QA Support.

We will answer your questions in an initial consultation. Sascha Manthei will take the time to go through them with you.

Book an initial consultation
Can we book individual services, or only the full consulting package?

Both. You can commission a single module, such as an audit, the qualification of premises or new equipment, or support for an upcoming inspection. Or you can book the full range, from setting up the quality system through validation and qualification to the inspection, as one end-to-end package. We start where the pressure on you is greatest today.

Who on your side is technically responsible, and can we reach that person directly?

Responsibility lies with a named, experienced consultant whom you can contact directly. You do not deal with an anonymous ticketing system but with the person accountable for your project. That is the core of our model: personal advice and continuity instead of changing contacts.

What does qualification from DQ to PQ mean in practice for our equipment and premises?

We start with a risk assessment and then take you through all four qualification stages: design qualification (DQ) for specification and selection, installation qualification (IQ) for correct installation, operational qualification (OQ) to demonstrate that the equipment functions as specified, and performance qualification (PQ) to demonstrate reproducible performance in routine operation. Equipment and premises are covered alike, each with traceable documentation for reliable production.

An inspection has been announced. How can you support us at short notice?

We first get a complete overview of your quality system and close the gaps we find in a structured, risk-based way. During the inspection, we support you on site, and afterwards we help you address the observations and define corrective and preventive actions. How much can be achieved in the time remaining depends on your starting point; we give you an honest assessment in the first, no-obligation conversation.

Do we need our own laboratory for method validation?

No. We carry out analytical method validation, from method development through the validation plan and execution to the validation report, in our GMP-compliant, fully digitalised laboratory. This also makes the service suitable for companies without their own analytical laboratory, including virtual pharma companies.

How does a product or process transfer work with you?

We plan the product transfer in a structured way, carry out the process validation at the receiving site and document the outcome in a GMP process validation report. This demonstrates that the transferred process consistently delivers product of the required quality, which is the basis for routine production and batch release.

Services that are often used together

Tell us about your project.

Call us or write a few lines. You will reach someone who can assess your request with real expertise.

Life Science Nord

As a member of the Life Science Nord cluster, we benefit from a strong, innovative network and work with other experts in the industry on forward-looking developments.

Scientist.com Registered Supplier

As a registered supplier on Scientist.com, we can also be reached through this platform: companies registered there can send their project requests directly to us.